InpharmD Analysis: $6M Raised
What is InpharmD?
InpharmD provides clinical pharmacist-reviewed, AI-generated drug information and custom literature searches for clinical questions. The site describes the product as a one-touch literature search with curated, evidence-based responses, including an AnswerGPT feature. It says more than 10,000 clinical pharmacists and over 30 health systems use the service.
Location
3423 Piedmont Rd NE, Atlanta, Georgia 30324, United States
Employees
11-50
Founded
2018
Revenue
$2-5M
Product Features & Capabilities
- One touch literature search, custom literature search for clinical questions, actionable drug information in real time, tailored responses to clinical inquiries, 95,954 clinical pharmacist hours saved, 100% customer satisfaction rate.
Pricing
- Up to 30 seats: $500/seat/month
- 30 - 200 seats: $400/seat/month
- 200 - 1000 seats: $300/seat/month
- 1000+ seats: Pricing available upon inquiry
How much InpharmD raised
Seed - $6.05 million
December 9, 2023Lead Investor: Led by 645 Ventures
Who are the founders of InpharmD
AA
Ashish Advani
Founder
TR
Tulasee Rao Chintha
Founder
Investors
- 645 Ventures
- Atlanta Ventures
- Y Combinator
- Qlarant Capital
- SF ELC
Competitors Overview
InpharmD operates in the clinical pharmacy market, providing a platform for clinical pharmacists to conduct custom literature searches and obtain curated responses to clinical questions. Its main competitors include:
-
WhizAI: Focuses on AI-driven insights for healthcare providers, helping them make informed decisions based on data analytics. WhizAI's advantage lies in its ability to provide real-time insights and predictive analytics, which can enhance clinical decision-making.
-
Synapse Medicine: Offers a clinical decision support tool that analyzes drug interactions and contraindications, aiming to prevent medication errors. Its strength is in its comprehensive medication management capabilities, which can optimize drug regimens throughout the patient care journey.
-
HealthEC: Provides a platform that promotes personalized healthcare through analytics and integrated tools. Its advantage is in its focus on interoperability and comprehensive analytics, which can help healthcare providers address care gaps and improve performance metrics.
-
Epocrates: A well-known mobile app that provides drug information, clinical guidelines, and decision support tools. Its advantage is its widespread use and accessibility, making it a go-to resource for many healthcare professionals.
-
Fullscript: Specializes in providing a platform for integrative medicine, allowing healthcare providers to prescribe supplements and medications. Its unique selling point is its focus on holistic health and wellness, which may appeal to a different segment of the market.
-
PharMerica: A pharmacy services company that provides medication management and consulting services. Its advantage is its extensive experience in long-term care and institutional pharmacy services.
InpharmD differentiates itself by offering clinical pharmacist-reviewed, AI-generated drug information, which may provide a more tailored and reliable service compared to traditional drug information services.
Business Model
Charges per seat for users, aiming to convert health systems into customers for revenue.
Market Focus
InpharmD primarily focuses on the healthcare industry, specifically in the area of clinical pharmacy. They provide a platform that assists clinical pharmacists in conducting literature searches to enhance patient care.
See something that needs updating? Suggest edits to this profile.